Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1
Top News: AVEO Pharmaceuticals (NASDAQ:AVEO), Aemetis (NASDAQ:AMTX), JetBlue Airways Corporation (NASDAQ:JBLU), Kingstone Companies (NASDAQ:KINS), Banro Corporation (NYSEMKT:BAA) - Property Mentor Group

Top News: AVEO Pharmaceuticals (NASDAQ:AVEO), Aemetis (NASDAQ:AMTX), JetBlue Airways Corporation (NASDAQ:JBLU), Kingstone Companies (NASDAQ:KINS), Banro Corporation (NYSEMKT:BAA)


On March 6, AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced the presentation of final results, including a predefined biomarker analysis, from the BATON- (Biomarker Assessment of Tivozanib in ONcology) CRC study, a randomized Phase 2 clinical trial of modified FOLFOX6 combined with tivozanib or bevacizumab in metastatic colorectal cancer (CRC). The BATON-CRC study enrolled a total of 265 patients randomized 2 to 1 to receive tivozanib in combination with mFOLFOX6 (n=177) compared to bevacizumab and mFOLFOX6 (n=88) as first-line treatment in patients with advanced metastatic CRC. On Friday shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) closed at $1.50. Company’s sales growth for last 5 years was -41.90%.

Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host an earnings review and business update call following the release of its fourth quarter/2014 year-end earnings report on Thursday, March 12, 2015. Aemetis, Inc. (NASDAQ:AMTX) in last trading activity increased 4.04% to close at $4.96. Company weekly performance is 12.27% while its quarterly performance stands at 8.12%. Aemetis, Inc. (NASDAQ:AMTX) is -62.66% away from its 52 week high.

On March 6, it was reported that, JetBlue Airways Corporation (Nasdaq:JBLU) opened the doors to its new crewmember hotel — The Lodge at OSC (Orlando Support Center) — located on the airline’s state-of-the-art JetBlue University training campus. JetBlue’s investment in The Lodge reinforces the airline’s commitment to its differentiated culture by ensuring crewmembers are immersed in that culture throughout their training at JetBlue University. On Friday shares of JetBlue Airways Corporation (NASDAQ:JBLU) closed at $17.18. Company’s sales growth for last 5 years was 12.10% and EPS growth for next 5 years is recorded as 43.30%.

Kingstone Companies, Inc. (NASDAQ:KINS) announced that the Company’s Chief Executive Officer, Mr. Barry Goldstein, will present at the following investor conference during March 2015. Institutional investors are encouraged to attend. Wednesday, March 11, 2015: Houlihan Lokey’s Financial Services Industry Conference at the Marriot Marquis in New York, NY. Kingstone Companies, Inc. (NASDAQ:KINS) has 11.30% insider ownership while its institutional ownership stands at 37.80%. In last trading activity company’s stock closed at $8.00.

On February 27, Banro Corporation (NYSEMKT:BAA) announced that it has signed definitive agreements for two gold forward sale transactions relating to the Twangiza mine and a gold streaming transaction relating to the Namoya mine, providing total gross proceeds to the Company of US$100 million. On last trading day Banro Corporation (NYSEMKT:BAA) decreased -13.64% to close at $0.19. Its volatility for the week is 15.97% while volatility for the month is 12.03%. BAA’s EPS growth for past 5 years was 15.00%. Banro Corporation (NYSEMKT:BAA) monthly performance is 18.75%.


Leave a Reply

Your email address will not be published. Required fields are marked *